BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7021879)

  • 1. Immunofluorescence for prostatic acid phosphatase: clinical applications.
    Pontes JE; Rose NR; Ercole C; Pierce JM
    J Urol; 1981 Aug; 126(2):187-9. PubMed ID: 7021879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical acid phosphatase level and tumor grade in prostatic carcinoma.
    Bentz MS; Cohen C; Demers LM; Budgeon LR
    Arch Pathol Lab Med; 1982 Sep; 106(9):476-80. PubMed ID: 6287961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
    Broghamer WL; Richardson ME; Faurest S; Parker JE
    Acta Cytol; 1985; 29(3):274-8. PubMed ID: 3890441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical prostatic acid phosphatase level as a prognostic factor of prostatic carcinoma.
    Sakai H; Shiraishi K; Minami Y; Yushita Y; Kanetake H; Saito Y
    Prostate; 1991; 19(3):265-72. PubMed ID: 1946042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistological localization of prostatic acid phosphatase.
    Ablin RJ
    Allergol Immunopathol (Madr); 1979; 7(5):361-4. PubMed ID: 395841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry of prostatic acid phosphatase.
    Nadji M; Morales AR
    Ann N Y Acad Sci; 1982; 390():133-41. PubMed ID: 7046588
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone marrow acid phosphatase by radioimmunoassay.
    Belville WD; Cox HD; Mahan DE; Olmert JP; Mittemeyer BT; Bruce AW
    Cancer; 1978 Jun; 41(6):2286-91. PubMed ID: 77719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical identification of prostatic acid phosphatase: correlation of tumor grade with acid phosphatase distribution.
    Bates RJ; Chapman CM; Prout GR; Lin CW
    J Urol; 1982 Mar; 127(3):574-80. PubMed ID: 6174741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical identification of prostatic epithelial cells in culture.
    Pontes JE; Choe B; Rose N; Pierce JM
    Invest Urol; 1979 May; 16(6):483-5. PubMed ID: 87387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine needle aspiration cytology of prostatic adenocarcinoma metastatic to the lung confirmed by the immunoperoxidase technique.
    Bartziota EV
    Acta Cytol; 1986; 30(5):497-500. PubMed ID: 2430390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case report of a high serum acid phosphatase level in metastatic prostatic adenocarcinoma.
    Sullivan H; Murthy NR
    J Urol; 1971 Sep; 106(3):404. PubMed ID: 5097194
    [No Abstract]   [Full Text] [Related]  

  • 12. Carcinoma of the prostate with bilateral breast metastases.
    Seipel WD; Malament M
    J Am Geriatr Soc; 1972 Oct; 20(10):510-3. PubMed ID: 5078087
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone marrow acid phosphatase in staging prostatic carcinoma.
    Pontes JE; Alcorn SW; Thomas AJ; Pierce JM
    J Urol; 1975 Sep; 114(3):422-4. PubMed ID: 1142527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
    Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB
    Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acid phosphatase in the bone marrow: diagnostic value in prostatic carcinoma].
    Tenaillon M; Billon B; Kelly A; Toppercer A; Elhilali MM
    J Urol (Paris); 1980; 86(2):107-10. PubMed ID: 7452042
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostatic cancer presenting as metastatic adenocarcinoma of undetermined origin. Immunodiagnosis by prostatic acid phosphatase.
    Yam LT; Winkler CF; Janckila AJ; Li CY; Lam KW
    Cancer; 1983 Jan; 51(2):283-7. PubMed ID: 6336978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical studies of prostatic acid phosphatase.
    Choe BK; Pontes EJ; McDonald I; Rose NR
    Cancer Treat Rep; 1977; 61(2):201-4. PubMed ID: 68823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Composite carcinoma of the prostate combining a small cell carcinoma and an adenocarcinoma. Apropos of a case].
    Kantelip B; Viallard JL; Costes-Chalret N; Francannet P
    Ann Pathol; 1989; 9(2):121-5. PubMed ID: 2544191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect immunofluorescence for identification of prostatic epithelial cells.
    Pontes JE; Choe B; Rose N; Pierce JM
    J Urol; 1977 Apr; 117(4):459-63. PubMed ID: 321808
    [No Abstract]   [Full Text] [Related]  

  • 20. The significance of prostatic acid phosphatase in adenocarcinoma of the prostate.
    Bruce AW; Mahan DE; Sullivan LD; Goldenberg L
    J Urol; 1981 Mar; 125(3):357-60. PubMed ID: 6162968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.